Non-Small Cell Lung Cancer (NSCLC) Treatment Market Size and Forecast to 2030.
%20Treatment%20Market.jpg)
The report "Non-Small Cell Lung Cancer (NSCLC) Treatment Market by Drug Class (Angiogenesis Inhibitors, Epidermal Growth Factor Receptor Blockers, Kinase Inhibitors, Microtubule Stabilizers, Folate Antimetabolites, and PD-1/ PD-L1 Inhibitors), by Application (Large Cell (Undifferentiated) Carcinoma, Squamous Cell (Epidermoid) Carcinoma, Adenocarcinoma, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Forecasts to 2030" The global Non-Small Cell Lung Cancer (NSCLC) Treatment Market is projected to reach USD 12.3 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing investment for the development of new therapy. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=23667 Competitive Dashboard: The prominent key players operating in the global Non-Small Cell...